{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:32:20Z","timestamp":1789115540470,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15967-7","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:22:17Z","timestamp":1788841337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond CA-125: circulating cell-free DNA as the next-generation biomarker in ovarian malignancy"],"prefix":"10.1186","volume":"26","author":[{"given":"Gamalat A.","family":"Elgedawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha A.","family":"Adbelmoneum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira I.","family":"Aldesoky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samya S.","family":"Mashal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany E.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8786-0190","authenticated-orcid":false,"given":"Naglaa S.","family":"Elabd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa L.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"2","key":"15967_CR1","first-page":"332","volume":"10","author":"T Baker","year":"2024","unstructured":"Baker T. Early Detection, Symptoms, and Treatment Options for Ovarian Cancer. Int J Adv Eng Technol Innovations (IJAETI). 2024;10(2):332\u201343. https:\/\/ijaeti.com\/index.php\/Journal\/article\/view\/446.","journal-title":"Int J Adv Eng Technol Innovations (IJAETI)"},{"key":"15967_CR2","unstructured":"Worldovariancancercoalition.org. THE WORLD OVARIAN CANCER COALITION ATLAS. 2019. Available at: https:\/\/worldovariancancercoalition.org\/wp-content\/uploads\/2018\/10\/THE-WORLD-OVARIAN-CANCER-COALITION-ATLAS-2018.pdf. [Accessed October 2019]."},{"issue":"10","key":"15967_CR3","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1200\/JCO.23.00141","volume":"42","author":"CY Han","year":"2024","unstructured":"Han CY, Lu KH, Corrigan G, Perez A, Kohring SD, Celestino J, et al. Normal Risk Ovarian Screening Study: 21-Year Update. J Clin Oncol. 2024;42(10):1102\u20139. Epub 2024 Jan 9. PMID: 38194613; PMCID: PMC11003507.","journal-title":"J Clin Oncol"},{"issue":"10290","key":"15967_CR4","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","volume":"397","author":"U Menon","year":"2021","unstructured":"Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397(10290):2182\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(21)00731-5. Epub 2021 May 12. PMID: 33991479; PMCID: PMC8192829.","journal-title":"Lancet"},{"issue":"11","key":"15967_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/cancers10110433","volume":"10","author":"J Kim","year":"2018","unstructured":"Kim J, Park EY, Kim O, Schilder JM, Coffey DM, Cho CH, et al. Cell Origins of High-Grade Serous Ovarian Cancer. Cancers (Basel). 2018;10(11):433. https:\/\/doi.org\/10.3390\/cancers10110433. PMID: 30424539; PMCID: PMC6267333.","journal-title":"Cancers (Basel)"},{"key":"15967_CR6","doi-asserted-by":"publisher","first-page":"11517","DOI":"10.2147\/OTT.S227156","volume":"12","author":"Q Chen","year":"2019","unstructured":"Chen Q, Zhang ZH, Wang S, Lang JH. Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer. Onco Targets Ther. 2019;12:11517\u201330. PMID: 31920340; PMCID: PMC6938177.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"15967_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41422-020-00457-7","volume":"31","author":"L Chen","year":"2021","unstructured":"Chen L, Abou-Alfa GK, Zheng B, Liu JF, Bai J, Du LT, et al. Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients. Cell Res. 2021;31(5):589\u201392. https:\/\/doi.org\/10.1038\/s41422-020-00457-7. Epub 2021 Feb 15. PMID: 33589745; PMCID: PMC8089097.","journal-title":"Cell Res"},{"key":"15967_CR8","doi-asserted-by":"crossref","unstructured":"Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol. 2014;32(6):579\u2009\u2013\u200986. doi: 10.1200\/JCO.2012.45.2011. Epub 2014 Jan 21. PMID: 24449238; PMCID: PMC4820760.","DOI":"10.1200\/JCO.2012.45.2011"},{"issue":"4","key":"15967_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17(4):223\u201338. https:\/\/doi.org\/10.1038\/nrc.2017.7. Epub 2017 Feb 24. PMID: 28233803.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"15967_CR10","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.3802\/jgo.2025.36.e5","volume":"36","author":"A Jamieson","year":"2025","unstructured":"Jamieson A, McConechy MK, Lum A, Senz J, Dowhy T, Huntsman DG, et al. Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas. J Gynecol Oncol. 2025;36(1):e5. https:\/\/doi.org\/10.3802\/jgo.2025.36.e5. Epub 2024 Jun 17. PMID: 38909641; PMCID: PMC11791001.","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"15967_CR11","first-page":"1551","volume":"19","author":"C Hufnagl","year":"2020","unstructured":"Hufnagl C, Leisch M, Weiss L, Melchardt T, Moik M, Asslaber D, et al. Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer. Oncol Lett. 2020;19(2):1551\u20138. Epub 2019 Dec 9. PMID: 31966080; PMCID: PMC6956108.","journal-title":"Oncol Lett"},{"key":"15967_CR12","doi-asserted-by":"publisher","first-page":"101431","DOI":"10.1016\/j.gore.2024.101431","volume":"54","author":"SH Kim","year":"2024","unstructured":"Kim SH, Weigelt B. Circulating cell-free (cf)DNA analysis: Current technologies and applications in gynecologic cancer. Gynecol Oncol Rep. 2024;54:101431. https:\/\/doi.org\/10.1016\/j.gore.2024.101431. PMID: 38947418; PMCID: PMC11211888.","journal-title":"Gynecol Oncol Rep"},{"issue":"2","key":"15967_CR13","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139. Epub 2017 Jan 17. PMID: 28094848.","journal-title":"CA Cancer J Clin"},{"key":"15967_CR14","doi-asserted-by":"publisher","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026. PMID: 19097774.","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"15967_CR15","doi-asserted-by":"publisher","unstructured":"Azar J, Kaddoura T, Timonian MA, Karam ES, Abou-Kheir W, Daoud G. Ovarian cancer in the Arab world: An updated review, Gene Reports, 37, 2024, https:\/\/doi.org\/10.1016\/j.genrep.2024.102025","DOI":"10.1016\/j.genrep.2024.102025"},{"key":"15967_CR16","doi-asserted-by":"crossref","unstructured":"Barbosa A, Peixoto A, Pinto P, Pinheiro M, Teixeira MR. Potential clinical applications of circulating cell-free DNA in ovarian cancer patients. Expert Rev Mol Med. 2018;20:e6. doi: 10.1017\/erm.2018.5. PMID: 30558693.","DOI":"10.1017\/erm.2018.5"},{"issue":"1","key":"15967_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1\u20135. https:\/\/doi.org\/10.1016\/j.ijgo.2013.10.001. Epub 2013 Oct 22. PMID: 24219974.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"15967_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ajme.2012.03.003","volume":"48","author":"ER Zaher","year":"2012","unstructured":"Zaher ER, Anwar MM, Kohail HMA, El-Zoghby SM, Abo-El-Eneen MS. Value of circulating DNA concentration and integrity as a screening test for detection of cancer in an Egyptian cohort. Alexandria J Med. 2012;48(3):187\u201396. https:\/\/doi.org\/10.1016\/j.ajme.2012.03.003.","journal-title":"Alexandria J Med"},{"issue":"6","key":"15967_CR19","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.3892\/ol.2015.3771","volume":"10","author":"X Shao","year":"2015","unstructured":"Shao X, He Y, Ji M, Chen X, Qi J, Shi W, et al. Quantitative analysis of cell-free DNA in ovarian cancer. Oncol Lett. 2015;10(6):3478\u201382. https:\/\/doi.org\/10.3892\/ol.2015.3771. Epub 2015 Sep 30. PMID: 26788153; PMCID: PMC4665352.","journal-title":"Oncol Lett"},{"issue":"8","key":"15967_CR20","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/cncr.24997","volume":"116","author":"AA Kamat","year":"2010","unstructured":"Kamat AA, Baldwin M, Urbauer D, Dang D, Han LY, Godwin A, et al. Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. Cancer. 2010;116(8):1918\u201325. https:\/\/doi.org\/10.1002\/cncr.24997. PMID: 20166213; PMCID: PMC2854845.","journal-title":"Cancer"},{"issue":"224","key":"15967_CR21","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra24. https:\/\/doi.org\/10.1126\/scitranslmed.3007094. PMID: 24553385; PMCID: PMC4017867.","journal-title":"Sci Transl Med"},{"issue":"3","key":"15967_CR22","doi-asserted-by":"publisher","first-page":"e70142","DOI":"10.1002\/cnr2.70142","volume":"8","author":"Z Momenimovahed","year":"2025","unstructured":"Momenimovahed Z, Mazidimoradi A, Allahqoli L, Salehiniya H. The Role of CA-125 in the Management of Ovarian Cancer: A Systematic Review. Cancer Rep (Hoboken). 2025;8(3):e70142. https:\/\/doi.org\/10.1002\/cnr2.70142. PMID: 40067023; PMCID: PMC11894717.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"6","key":"15967_CR23","first-page":"435","volume":"24","author":"SV Antovska","year":"2011","unstructured":"Antovska SV, Bashevska N, Aleksioska N. Predictive Values of the Ultrasound Parameters, CA-125 and Risk of Malignancy Index in Patients With Ovarian Cancer. Klinicka Onkologie: Casopis Ceske Slovenske Onkologicke Spolecnosti. 2011;24(6):435\u201342.","journal-title":"Klinicka Onkologie: Casopis Ceske Slovenske Onkologicke Spolecnosti"},{"issue":"4","key":"15967_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.5114\/ceh.2021.111060","volume":"7","author":"HS Sabry","year":"2021","unstructured":"Sabry HS, Tayel SI, Enar ME, Elabd NS. Differential expression of long noncoding RNA in hepatocellular carcinoma on top of chronic HCV and HBV infections. Clin Exp Hepatol. 2021;7(4):337\u201350. https:\/\/doi.org\/10.5114\/ceh.2021.111060. Epub 2021 Dec 8. PMID: 35402718; PMCID: PMC8977880.","journal-title":"Clin Exp Hepatol"},{"issue":"4","key":"15967_CR25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00404-021-06017-7","volume":"304","author":"J Chen","year":"2021","unstructured":"Chen J, Wang J, Cao D, Yang J, Shen K, Huang H, et al. Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases. Arch Gynecol Obstet. 2021;304(4):1043\u201353. https:\/\/doi.org\/10.1007\/s00404-021-06017-7. Epub 2021 Mar 9. PMID: 33751209; PMCID: PMC7942666.","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"15967_CR26","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.4161\/cbt.5.10.3240","volume":"5","author":"AA Kamat","year":"2006","unstructured":"Kamat AA, Bischoff FZ, Dang D, Baldwin MF, Han LY, Lin YG, et al. Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma. Cancer Biol Ther. 2006;5(10):1369\u201374. https:\/\/doi.org\/10.4161\/cbt.5.10.3240. Epub 2006 Oct 26. PMID: 16969071.","journal-title":"Cancer Biol Ther"},{"key":"15967_CR27","doi-asserted-by":"publisher","unstructured":"Zachariah RR, Schmid S, Buerki N, Radpour R, Holzgreve W, Zhong X. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. Obstet Gynecol. 2008;112(4):843\u201350. https:\/\/doi.org\/10.1097\/AOG.0b013e3181867bc0. PMID: 18827127.","DOI":"10.1097\/AOG.0b013e3181867bc0"},{"key":"15967_CR28","doi-asserted-by":"publisher","unstructured":"Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chass\u00e9 E, et al. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol. 2004;22(20):4157\u201364. https:\/\/doi.org\/10.1200\/JCO.2004.11.123. PMID: 15483026.","DOI":"10.1200\/JCO.2004.11.123"},{"key":"15967_CR29","doi-asserted-by":"publisher","unstructured":"Wei WI, Yuen AP, Ng RW, Ho WK, Kwong DL, Sham JS. Quantitative analysis of plasma cell-free Epstein-Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study. Head Neck. 2004;26(10):878\u201383. https:\/\/doi.org\/10.1002\/hed.20066. PMID: 15390201.","DOI":"10.1002\/hed.20066"},{"issue":"13","key":"15967_CR30","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","volume":"368","author":"SJ Dawson","year":"2013","unstructured":"Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013;368(13):1199\u2013209. https:\/\/doi.org\/10.1056\/NEJMoa1213261. Epub 2013 Mar 13. PMID: 23484797.","journal-title":"N Engl J Med"},{"key":"15967_CR31","doi-asserted-by":"publisher","unstructured":"Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71\u201388. https:\/\/doi.org\/10.1038\/s41576-018-0071-5. PMID: 30410101.","DOI":"10.1038\/s41576-018-0071-5"},{"issue":"8","key":"15967_CR32","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/annonc\/mdv177","volume":"26","author":"J Tie","year":"2015","unstructured":"Tie J, Kinde I, Wang Y, Wong HL, Roebert J, Christie M, et al. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann Oncol. 2015;26(8):1715\u201322. https:\/\/doi.org\/10.1093\/annonc\/mdv177. Epub 2015 Apr 7. PMID: 25851626; PMCID: PMC4511218.","journal-title":"Ann Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15967-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:42:02Z","timestamp":1789112522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15967-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15967"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15967-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The National Liver Institute\u2019s Research Ethics Committee at Menoufia University in Egypt reviewed and approved the study (Approval Number: IRB 00466\/2023), and it was carried out in compliance with the Declaration of Helsinki. Prior to enrolment, all participants gave their written informed consent, enabling the use of their blood samples and medical records for research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1088"}}